2002 Randomized, double-blind study on The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Abdominal Infections.
Sponsor: Wyeth Research
Phase III
2008 A Multinational, Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Sponsor: Sanofi-Aventis
Phase III
2008 A Phase 2 Double-Blind, Placebo Controlled, Multi-Center Adjuvant Trial of the Efficacy, Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing Mutant Ras Protein Combined With a Gemcitabine Regimen Versus a Gemcitabine Regimen With Placebo, in Patients With Post-Resection R0/R1 Pancreatic Cancer With Tumor Sequence Confirmation of Ras Mutations.
Sponsor: Globeimmune
Phase II
2009 Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
Sponsor: Novexel Inc.
Phase II
2011 Randomized, double-blind, double-dummy, multicenter, prospective study to Compare TP-434 and Ertapenem in CA Complicated Intra-abdominal Infections.
Sponsor: Tetraphase Pharmaceuticals, Inc.
Phase II